CAS 864953-39-9

Fostemsavir Tris

CAS : 864953-39-9

Fostemsavir Tris (BMS-663068 Tris) is the prodrug of BMS-626529,is a oral, safe and effective inhibitor of HIV-1 attachment.

Formule : C₂₉H₃₇N₈O₁₁P

Degré de pureté : 99.45%

Couleur et forme : Solid

Masse moléculaire : 704.62

Ref: TM-T10570

2-Amino-2-(Hydroxymethyl)Propane-1,3-Diol (3-(2-(4-Benzoylpiperazin-1-Yl)-2-Oxoacetyl)-4-Methoxy-7-(3-Methyl-1H-1,2,4-Triazol-1-Yl)-1H-Pyrrolo[2,3-C]Pyridin-1-Yl)Methyl Phosphate

CAS : 864953-39-9

2-Amino-2-(Hydroxymethyl)Propane-1,3-Diol (3-(2-(4-Benzoylpiperazin-1-Yl)-2-Oxoacetyl)-4-Methoxy-7-(3-Methyl-1H-1,2,4-Triazol-1-Yl)-1H-Pyrrolo[2,3-C]Pyridin-1-Yl)Methyl Phosphate

Degré de pureté : 98+%

Masse moléculaire : 704.62g/mol

Ref: 54-OR1024349

Fostemsavir Tris

CAS : 864953-39-9

Fostemsavir Tris

Degré de pureté : ≥98%

Masse moléculaire : 704.62g/mol

Ref: 54-BUP02409

Fostemsavir Tromethamine

CAS : 864953-39-9

Formule : C₂₅H₂₆N₇O₈P·C₄H₁₁NO₃

Masse moléculaire : 583.50 121.14

Ref: 4Z-F-247001

Fostemsavir Tris

CAS : 864953-39-9

Fostemsavir Tris is an inhibitor compound that inhibits the activity of chemokines. Chemokines are a type of protein that regulates inflammatory responses. Fostemsavir Tris blocks the binding site for chemokines on the surface of immune cells, preventing them from interacting with their receptors and initiating an inflammatory response. This drug has been used in clinical trials as a treatment for HIV infection and influenza. Fostemsavir Tris has also been shown to inhibit the replication of herpes simplex virus and other viruses that infect humans, such as influenza and hepatitis C virus.

Formule : C₂₉H₃₇N₈O₁₁P

Degré de pureté : Min. 95%

Masse moléculaire : 704.62 g/mol

Ref: 3D-PJB95339

Fostemsavir Tris

CAS : 864953-39-9

Formule : C₂₉H₃₇N₈O₁₁P

Degré de pureté : %

Couleur et forme : Solid

Masse moléculaire : 704.6248410000004

Ref: IN-DA00GU1Y